Director Tomer Berkovitz files initial Form 3 at SOPHiA GENETICS (SOPH)

Rhea-AI Filing Summary

SOPHiA GENETICS SA director Tomer Berkovitz filed an initial Form 3, which is a baseline report of insider status and equity interests. This filing does not list any insider transactions or derivative positions in the provided data, and serves as an initial ownership disclosure for this director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/18/2026 - 09:47 AM Learn about SEC filing dates

FAQ

What does Tomer Berkovitz’s Form 3 for SOPH indicate?

The Form 3 shows that Tomer Berkovitz is a director of SOPHiA GENETICS SA (SOPH). It serves as his initial insider ownership and status report, with no transactions disclosed in the provided data.

Are any SOPH insider trades reported in this Form 3 filing?

No insider trades are reported in this Form 3 excerpt. The transaction summary shows zero buy, sell, acquire, or dispose entries, indicating no reportable transactions in this filing data.

Does the SOPH Form 3 show any option or derivative positions?

The provided Form 3 data lists no derivative positions. The derivative summary is empty and exercise-related counts are zero, so no stock options or similar instruments are disclosed here.

Why is a Form 3 important for SOPH investors?

Form 3 establishes an insider’s baseline status at SOPHiA GENETICS SA. It helps investors understand who qualifies as an insider and creates a starting point for tracking future Form 4 or Form 5 trading activity.

Does this SOPH Form 3 imply any change in ownership?

The Form 3 itself does not imply a change in ownership. It is an initial disclosure for director Tomer Berkovitz, and the summary shows no reported transactions affecting his holdings in this filing data.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Berkovitz Tomer

(Last) (First) (Middle)

C/O SOPHIA GENETICS INC.

401 PARK DRIVE, FLOOR 5

(Street)

BOSTON MASSACHUSETTS 02215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit list - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Elimara Brunetto as Attorney-in- Fact for Tomer Berkovitz	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)